Sarecycline Seysara denied as not medically necessary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for sarecycline seysara are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied Sarecycline (Seysara) for Medical Necessity

Blue Cross Blue Shield's medical-necessity denial means the plan determined that the submitted information did not demonstrate that sarecycline was required for your condition under the plan's coverage criteria. For acne medications, BCBS typically requires documentation of diagnosis severity, failure or contraindication of lower-cost alternatives, and evidence that the chosen agent is the clinically appropriate treatment for your specific presentation.

### Why This Denial Is Appealable

Medical-necessity determinations are clinical judgments, not absolute rulings. If your prescriber has clinical documentation supporting the diagnosis severity and the rationale for sarecycline — such as prior treatment failures, documented intolerances, or clinical characteristics that make sarecycline the appropriate choice — that evidence can overcome the denial. BCBS must evaluate the full clinical record, not just the initial prior-authorization submission.

### Federal Appeal Framework

• Internal appeal: Under ERISA §503 (employer plans) or ACA §2719 (individual/small-group plans), you are entitled to a full-and-fair review of all clinical documentation submitted. File within the deadline on your denial letter.
• External review: After an adverse internal outcome, request independent external review under ACA §2719. The window is typically around four months from the final denial — verify the exact date.
• Expedited review: If delay would worsen your condition, request expedited processing in writing; decisions are required within days.

### Concrete Appeal Steps

1. Read the denial letter carefully to identify which medical-necessity criterion BCBS says was not met. 2. Obtain BCBS's published medical or coverage policy for sarecycline or acne treatments to understand all required criteria. 3. Gather all clinical documentation that addresses the unmet criterion. 4. Have your dermatologist or prescriber write a detailed medical-necessity letter that addresses each criterion directly with specific chart evidence. 5. Submit the internal appeal with all supporting records, organized criterion by criterion. 6. If the internal appeal is denied, escalate to external review with the same documentation package.

### Documentation to Gather

• Diagnosis confirmation: Chart notes documenting acne vulgaris diagnosis, clinical severity, and affected body areas.
• Prior-treatment history: Pharmacy records and visit notes documenting each prior antibiotic or topical therapy tried, with start/stop dates and documented reason for stopping (failure, intolerance, contraindication).
• Clinical severity documentation: Photographs, lesion counts, or standardized severity assessments from the chart showing current disease burden.
• Prescriber medical-necessity letter: A letter from your dermatologist or prescriber that maps each BCBS criterion to a specific, documented chart fact.
• Relevant guideline reference: If the applicable dermatology society guideline (such as the relevant AAD guideline) supports the treatment approach, your prescriber may reference the organization and its general recommendation without needing to cite specific statistics.

### Criteria-Mapping Structure

Create a two-column table: in the left column, copy each requirement verbatim from BCBS's coverage policy; in the right column, write the exact chart fact (date, note, lab result) that satisfies it. Leave nothing implied. Every row must be answered.